Jiang Lin Attorney
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 15290677 | (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE TABLET FORMULATIONS WITH IMPROVED STABILITY | C07C, A61K | Oct 10, 2016 | Sep 12, 2018 |
| 14880777 | METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS | A61K | Oct 11, 2015 | Sep 9, 2018 |
| 14537218 | SUBSITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS | C07D | Nov 9, 2014 | Apr 7, 2016 |
| 14504970 | METHODS FOR TREATING CANCER USING PI3K INHIBITOR AND MEK INHIBITOR | A61K | Oct 1, 2014 | Jun 13, 2016 |
| 14314780 | Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals | C07D, A61K, C07C | Jun 24, 2014 | May 2, 2016 |
| 14265433 | (Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUORMETHYLPHENYL)-AMIDE TABLET FORMULATIONS WITH IMPROVED STABILITY | C07C | Apr 29, 2014 | Nov 27, 2016 |
| 14260928 | METHODS FOR REDUCING THE RISK OF CONVERSION TO CLINICALLY DEFINITE MULTIPLE SCLEROSIS | A61K | Apr 23, 2014 | Aug 21, 2016 |
| 14204220 | SUBSITUTED 2-(CHROMAN-6-YLOXYL)-THIAZOLES AND THEIR USE AS PHARMACEUTICALS | C07F, C07D | Mar 10, 2014 | Jun 24, 2015 |
| 14172082 | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | A61K | Feb 3, 2014 | Nov 16, 2015 |
| 14091511 | Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals | A61K, C07D, C07C | Nov 26, 2013 | Apr 27, 2015 |
| 13912647 | COMPOSITIONS AND METHODS FOR TREATING CANCER USING PI3K INHIBITOR AND MEK INHIBITOR | A61K | Jun 6, 2013 | Aug 5, 2015 |
| 61815982 | METHODS FOR REDUCING THE RISK OF CONVERSION TO CLINICALLY DEFINITE MULTIPLE SCLEROSIS | Apr 24, 2013 | ||
| 61777361 | METHODS FOR REDUCING THE RISK OF AN ADVERSE TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION IN MULTIPLE SCLEROSIS PATIENTS | Mar 11, 2013 | ||
| 13770238 | USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS | A61K | Feb 18, 2013 | Mar 18, 2015 |
| 13755825 | USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS | A61K | Jan 30, 2013 | Jun 23, 2015 |
| 13544209 | 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases | A61P, A61K, C07D | Jul 8, 2012 | Mar 9, 2015 |
| 61512198 | USE OF TERIFLUNOMIDE FOR REDUCING OCCURRENCE OF RELAPSES REQUIRING HEALTHCARE RESOURCES | Jul 26, 2011 | ||
| 61489508 | USE OF TERIFLUNOMIDE FOR REDUCING RELAPSES LEADING TO HOSPITALIZATION | May 23, 2011 | ||
| 61487998 | USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS | May 18, 2011 | ||
| 61487940 | EFFECTS OF THERAPEUTIC TREATMENT WITH TERIFLUNOMIDE IN TRANSCRANIAL MAGNETIC STIMULATION-INDUCED MOTOR EVOKED POTENTIALS IN THE DA-RAT MODEL OF EAE | May 18, 2011 |